CYP27B1
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
Also known as: CP27B_HUMAN, CYP1, P450c1, PDDR, VDD1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15528
- Gene
- CYP27B1
- Ensembl
- ENSG00000111012
- Chromosome
- 12
- Canonical length
- 508 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the inner mitochondrial membrane where it hydroxylates 25-hydroxyvitamin D3 at the 1alpha position. This reaction synthesizes 1alpha,25-dihydroxyvitamin D3, the active form of vitamin D3, which binds to the vitamin D receptor and regulates calcium metabolism. Thus this enzyme regulates the level of biologically active vitamin D and plays an important role in calcium homeostasis. Mutations in this gene can result in vitamin D-dependent rickets type I. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
508 residues, UniProt reviewed canonical sequence.
>O15528|CYP27B1
1 MTQTLKYASR VFHRVRWAPE LGASLGYREY HSARRSLADI PGPSTPSFLA ELFCKGGLSR
61 LHELQVQGAA HFGPVWLASF GTVRTVYVAA PALVEELLRQ EGPRPERCSF SPWTEHRRCR
121 QRACGLLTAE GEEWQRLRSL LAPLLLRPQA AARYAGTLNN VVCDLVRRLR RQRGRGTGPP
181 ALVRDVAGEF YKFGLEGIAA VLLGSRLGCL EAQVPPDTET FIRAVGSVFV STLLTMAMPH
241 WLRHLVPGPW GRLCRDWDQM FAFAQRHVER REAEAAMRNG GQPEKDLESG AHLTHFLFRE
301 ELPAQSILGN VTELLLAGVD TVSNTLSWAL YELSRHPEVQ TALHSEITAA LSPGSSAYPS
361 ATVLSQLPLL KAVVKEVLRL YPVVPGNSRV PDKDIHVGDY IIPKNTLVTL CHYATSRDPA
421 QFPEPNSFRP ARWLGEGPTP HPFASLPFGF GKRSCMGRRL AELELQMALA QILTHFEVQP
481 EPGAAPVRPK TRTVLVPERS INLQFLDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP27B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- kidney: 19 nTPM
- thyroid gland: 5.3 nTPM
- retina: 3.1 nTPM
- pancreas: 2.8 nTPM
- urinary bladder: 2 nTPM
- adrenal gland: 1.4 nTPM
Single-cell type
- breast lactating cells: 17 nCPM
- proximal tubule cells: 7.2 nCPM
- epididymal efferent duct absorptive cells: 6.4 nCPM
- pancreatic acinar cells: 5 nCPM
- esophageal basal cells: 4.8 nCPM
- epicardial cells: 4.5 nCPM
Immune cell
- MAIT T-cell: 1.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- cerebral cortex: 0.4 nTPM
- white matter: 0.4 nTPM
- amygdala: 0.2 nTPM
- basal ganglia: 0.2 nTPM
- cerebellum: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CYP27B1.
Disease | AllUniProt
Conditions CYP27B1 is implicated in, by any mechanism.
- Rickets vitamin D-dependent 1A (VDDR1A) MIM:264700
Disease | GeneticClinVar
106 pathogenic / likely-pathogenic of 577 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Vitamin D-dependent rickets, type 1A
- Vitamin D-dependent rickets, type 1
- CYP27B1-related disorder
- Multiple sclerosis, susceptibility to
- Hepatocellular carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone mineralization
- calcitriol biosynthetic process from calciol
- calcium ion homeostasis
- calcium ion transport
- cellular response to vitamin D
- decidualization
- G1 to G0 transition
- negative regulation of cell growth
- negative regulation of cell population proliferation
- positive regulation of keratinocyte differentiation
- positive regulation of vitamin D receptor signaling pathway
- regulation of bone mineralization
- response to estrogen
- response to lipopolysaccharide
- response to type II interferon
- response to vitamin D
- vitamin D catabolic process
- vitamin D metabolic process
- vitamin metabolic process
Molecular functions
- heme binding
- iron ion binding
- calcidiol 1-monooxygenase activity
- secalciferol 1-monooxygenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP27B1 as an antibody target. Whether an autoantibody or antibody against CYP27B1 could matter depends on whether native CYP27B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP27B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP27B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...